Enterprise data indicates that U.S. service members (SMs) with posttraumatic stress disorder (PTSD) may not receive an evidence-based treatment (EBT) or may receive an EBT with low fidelity to the core components.
View Article and Find Full Text PDFPurpose: The purpose of this study is to develop a brief measure of problem areas experienced by patients following primary treatment for breast cancer.
Method: Systematic reviews of the quantitative and qualitative literature were used to inform selection of scale items using (1) valid and reliable items from a national item bank (patient reported outcomes measurement information system [PROMIS]), (2) existing scales from prior breast cancer survivorship research, or (3) items developed by the investigators.
Results: Participants (n = 400) were on average 51 years old, highly educated, Caucasian, diagnosed with stage I-III breast cancer, and a median of 1.
Objectives: Cancer survivors can experience difficulties returning to and/or remaining at work. Sociodemographic, health and well-being, symptom burden, functional limitations in relation to work demands, work environment, and various work policies and procedures can be related to work function.
Methods: This study analyzed cross-sectional data of a sample of cancer survivors (n = 1,525) who were diagnosed and treated for various types of cancer.
Background: Cancer survivors assume that stress plays an important role in cancer recurrence. However, the role of stress in the etiology of cancer recurrence remains unclear.
Objective: A systematic review examining the causal role of exposure to stressors and/or stress response and cancer recurrence was conducted.
Objective: To identify whether clusters of symptoms (depression, anxiety, fatigue, cognitive limitations) appear in employed breast cancer survivors, and whether clusters are related to job stress and aerobic activity.
Methods: Employed breast cancer survivors (n = 94) and women without a history of cancer (n = 100) completed questionnaires online in a cross-sectional study.
Results: A two-cluster solution of high or low symptom severity groups was observed.
Quality health care for survivors of cancer must evaluate and manage symptoms that are reported at the surveillance visit but are not linked to a cancer recurrence or a new cancer. At present, this does not always occur. This article analyzes quality of health care for survivors of cancer, taking empirical evidence and clinical expertise into consideration.
View Article and Find Full Text PDFObjective: Breast cancer survivors (BCS) who wish to stay actively employed following primary treatment of cancer may experience cognitive problems at work. Management of these cognitive problems may need to focus on associated symptoms. The current study determined whether fatigue and depressive symptoms, which can co-occur with one another, are independently and/or interactively related to cognitive limitations at work.
View Article and Find Full Text PDFObjectives: Previous research has suggested that endocrine therapy is associated with cognitive limitations in breast cancer survivors (BCS); this study examined the relationship in employed BCS, an average of three years post-primary treatment.
Methods: 77 BCS with past or current exposure to tamoxifen or aromatase inhibitors and 56 BCS with no history of endocrine therapy completed self-report measures of cognitive function, anxiety, depression, and fatigue as well as an online neurocognitive battery.
Results: Exposure to endocrine therapy was not related to scores on the objective measures, but moderately related to perceived attentional problems at work (β = -0.
Introduction: As with other illnesses, several variables can impact the transition back to the workplace, long-term work productivity, or job retention among cancer survivors. We developed a model related to work and cancer based in part on the general area of work disability and the specific literature on cancer survivors and work.
Methods: A systematic search of the literature on work and cancer was conducted to determine whether an evidence base existed to support the proposed model.
Background: The number of cancer survivors is steadily increasing. Following completion of primary cancer treatment and many years thereafter, specific symptoms continue to negatively affect cancer survivors. The purpose of this article is to review the evidence of symptom burden following primary treatment for cancer in survivors of the most common types of cancer (breast, gynecological, prostate, and colorectal).
View Article and Find Full Text PDFObjective: This study investigated performance-based and patient-reported cognitive limitations on work output.
Methods: Working breast cancer survivors (BCS) (n = 122) and a non-cancer comparison group (NCCG; n = 113) completed measures of cognitive function, fatigue, distress, job stress, and work output.
Results: Distress, fatigue, and job stress were higher in the BCS group who were on average 3-years post-treatment.
Women may have difficulty maintaining smoking cessation efforts due to negative affect and fear of weight gain. Dieting smokers who rely on cigarettes for affect regulation and weight management may be especially prone to weight gain and smoking relapse following initial smoking abstinence. The present study, which included 82 women smokers, assessed the relationship between dieting status, self-efficacy, and temptation to smoke and eat following a depressing or elating mood induction.
View Article and Find Full Text PDF